The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics

The potency of general anesthetics from different chemical classes was tested after pretreatment with subanesthetic doses of noncompetitive N-methyl-D-aspartate (NMDA) antagonists in mice. Changes in general anesthetic potency were assessed by determination of alteration of duration of loss of righting reflex for ethanol and pentobarbital and changes in the minimum alveolar concentration (MAC) for the volatile anesthetics, halothane and diethyl ether. The ability of the noncompetitive NMDA antagonists, MK-801 [(+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)cyclo-hepten-5,10-imine ], phencyclidine (PCP) and ketamine, to increase the potency of general anesthetics paralleled their potency as NMDA antagonists and their affinity for the PCP receptor site of the NMDA receptor-ionophore complex (MK-801 greater than PCP greater than ketamine). These results indicate that block of central NMDA receptors may contribute to the production of anesthesia by a variety of agents.

[1]  Balster Rl,et al.  The behavioral effects of phencyclidine in animals. , 1978 .

[2]  E. Eger,et al.  Minimum alveolar anesthetic concentration: a standard of anesthetic potency. , 1965, Anesthesiology.

[3]  M. Zornow,et al.  The noncompetitive N-methyl-d-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits , 1989, Neuropharmacology.

[4]  R. Nicoll,et al.  The effects of pentobarbital and related compounds on frog motoneurons , 1980, Brain Research.

[5]  D. Lodge,et al.  The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate , 1983, British journal of pharmacology.

[6]  W. J. Russell,et al.  The action of ether and methoxyflurane on synaptic transmission in isolated preparations of the mammalian cortex. , 1975, The Journal of physiology.

[7]  W. Koek,et al.  MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. , 1988, The Journal of pharmacology and experimental therapeutics.

[8]  J. Olney,et al.  The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics , 1986, Neuroscience Letters.

[9]  D. Gruol,et al.  Acute ethanol alters the firing pattern and glutamate response of cerebellar Purkinje neurons in culture , 1987, Brain Research.

[10]  C. D. Richards,et al.  ANAESTHETICS DEPRESS THE SENSITIVITY OF CORTICAL NEURONES TO l‐GLUTAMATE , 1976, British journal of pharmacology.

[11]  T. Honoré,et al.  Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons. , 1987, European journal of pharmacology.

[12]  M. Larrabee,et al.  Selective action of anesthetics on synapses and axons in mammalian sympathetic ganglia. , 1952, Journal of neurophysiology.

[13]  Balster Rl.  Clinical implications of behavioral pharmacology research on phencyclidine. , 1986 .

[14]  E. M. Landau,et al.  Anaesthetic and convulsant ethers act on different sites at the crab neuromuscular junction in vitro , 1977, Nature.

[15]  J. M. Moerschbaecher,et al.  Phencyclidine in combination with pentobarbital: Supra-additive effects on complex operant behavior in patas monkeys , 1982, Pharmacology Biochemistry and Behavior.

[16]  J. Barker,et al.  Pentobarbitone pharmacology of mammalian central neurones grown in tissue culture. , 1978, The Journal of physiology.

[17]  M. Mayer,et al.  Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique. , 1988, Journal of neurophysiology.

[18]  R. Balster,et al.  Interactions between phencyclidine and central nervous system depressants evaluated in mice and rats , 1987, Pharmacology Biochemistry and Behavior.

[19]  R. Harris,et al.  Neurochemical actions of anesthetic drugs on the gamma-aminobutyric acid receptor-chloride channel complex. , 1987, The Journal of pharmacology and experimental therapeutics.

[20]  R. Miller,et al.  Multiple sites for the regulation of the N-methyl-D-aspartate receptor. , 1988, Molecular pharmacology.

[21]  R. Sircar,et al.  The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/gd-receptor , 1987, Brain Research.

[22]  E. Albuquerque,et al.  Ethanol potentiates and blocks NMDA‐activated single‐channel currents in rat hippocampal pyramidal cells , 1989, FEBS letters.

[23]  B. Cabana,et al.  A study of the interaction of the hypnotic effects and of the toxic effects of chloral hydrate and ethanol. , 1970, The Journal of pharmacology and experimental therapeutics.

[24]  D. Gruol,et al.  Development of spontaneous and glutamate-evoked activity is altered by chronic ethanol in cultured cerebellar Purkinje neurons , 1987, Brain Research.

[25]  E. Wong,et al.  The novel anticonvulsant MK‐801 binds to the activated state of the N‐methyl‐d‐aspartate receptor in rat brain , 1987, British journal of pharmacology.

[26]  E. Pask,et al.  Effect of ether inhalation upon spinal cord and root action potentials , 1952, The Journal of physiology.

[27]  B. Tabakoff,et al.  N‐Methyl‐D‐Aspartate Receptors and Ethanol: Inhibition of Calcium Flux and Cyclic GMP Production , 1989, Journal of neurochemistry.

[28]  W. D. Winters,et al.  The cataleptic state induced by ketamine: a review of the neuropharmacology of anesthesia. , 1972, Neuropharmacology.

[29]  L. Iversen,et al.  The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G White,et al.  Ethanol inhibits NMDA-activated ion current in hippocampal neurons. , 1989, Science.

[31]  R. Reiffenstein,et al.  Toxicity of phencyclidine and ethanol in combination. , 1985, Alcohol and drug research.